New drug combo aims to slow aggressive lung cancer
Disease control
Recruiting now
This study tests a two-step treatment for people with extensive stage small cell lung cancer who have not had treatment before. First, patients receive standard chemotherapy plus immunotherapy. Then, they take two maintenance drugs (durvalumab and ceralasertib) to keep the cancer…
Phase: PHASE2 • Sponsor: Muhammad Furqan • Aim: Disease control
Last updated May 15, 2026 11:57 UTC